Literature DB >> 8901824

Vascular hypertrophy and remodeling in secondary hypertension.

D Rizzoni1, E Porteri, M Castellano, G Bettoni, M L Muiesan, P Muiesan, S M Giulini, E Agabiti-Rosei.   

Abstract

It has been proposed that several neurohumoral factors may be involved in the genesis of vascular structural changes (remodeling or hypertrophy) frequently observed in essential hypertension. Therefore, in this study we investigated vascular structural alterations of subcutaneous small resistance arteries in patients with secondary forms of hypertension. The study included 70 participants: 11 with pheochromocytoma, 13 with primary aldosteronism, and 17 with renovascular hypertension; 13 normotensive subjects and 16 patients with essential hypertension served as controls. All subjects were submitted to a biopsy of subcutaneous fat. Small resistance arteries were dissected and mounted on a micromyograph, and media-lumen ratio, media thickness, remodeling index, and growth index were evaluated. Endothelial function was evaluated according to the dose-response curve to acetylcholine. In patients with either primary aldosteronism or renovascular hypertension, a marked increase in media-lumen ratio was observed, whereas in patients with pheochromocytoma, the extent of vascular structural alterations was similar to that observed in patients with essential hypertension. The increase in media-lumen ratio in patients with essential hypertension and with pheochromocytoma was mainly due to vascular remodeling (remodeling index, 93% to 94%), whereas in patients with renovascular hypertension, there was vascular growth (remodeling index, 70%; growth index, 53%). Patients with primary aldosteronism had an intermediate pattern compared with the other two forms of secondary hypertension. An evident impairment of endothelial function was observed in all four hypertensive groups. In conclusion, the renin-angiotensin-aldosterone system seems to be more powerful than the adrenergic system in inducing vascular growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901824     DOI: 10.1161/01.hyp.28.5.785

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

Review 1.  Aldosterone and vascular damage.

Authors:  D Duprez; M De Buyzere; E R Rietzschel; D L Clement
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

3.  The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity.

Authors:  Fabrice M A C Martens; Frank L J Visseren
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 4.810

Review 4.  Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Authors:  Teresa M Seccia; Brasilina Caroccia; Gail K Adler; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-04       Impact factor: 10.190

Review 5.  Small artery remodelling in hypertension: causes, consequences and therapeutic implications.

Authors:  Michael J Mulvany
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

6.  MDM2: a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling.

Authors:  Yasuhiro Nakamura; Saya Suzuki; Takashi Suzuki; Katsuhiko Ono; Ikumi Miura; Fumitoshi Satoh; Takuya Moriya; Haruo Saito; Shogo Yamada; Sadayoshi Ito; Hironobu Sasano
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 7.  Interactions between macro- and micro-circulation: are they relevant?

Authors:  Damiano Rizzoni; Carolina De Ciuceis; Massimo Salvetti; Anna Paini; Claudia Rossini; Claudia Agabiti-Rosei; Maria Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-14

8.  Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia.

Authors:  Laura J Janke; Sara L Van Driest; Mary V Portera; Ravi V Atreya; Joshua C Denny; Deqing Pei; Cheng Cheng; Sue C Kaste; Hiroto Inaba; Sima Jeha; Ching-Hon Pui; Mary V Relling; Seth E Karol
Journal:  Blood       Date:  2019-08-13       Impact factor: 22.113

9.  Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.

Authors:  Carolina De Ciuceis; Massimo Salvetti; Anna Paini; Claudia Rossini; Maria Lorenza Muiesan; Sarah Duse; Stefano Caletti; Maria Antonietta Coschignano; Francesco Semeraro; Valentina Trapletti; Fabio Bertacchini; Valeria Brami; Alina Petelca; Enrico Agabiti Rosei; Damiano Rizzoni; Claudia Agabiti Rosei
Journal:  Intern Emerg Med       Date:  2017-06-24       Impact factor: 3.397

Review 10.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.